addiction. Mental and behavioural disorders due to use of opioids
Conditions
Interventions
Intervention 1: Intervention group: habb-o-shefa capsule( 500 mg ) dose: 1 cap three time a day for 12 weeks( 3 month). Intervention 2: control group: sugar capsule( 500 mg ) dose: 1 cap three time a
Treatment - Drugs
Placebo
Intervention group: habb-o-shefa capsule( 500 mg ) dose: 1 cap three time a day for 12 weeks( 3 month)
control group: sugar capsule( 500 mg ) dose: 1 cap three time a day for 12 weeks( 3 month)
Sponsors
Vice Chancellor for research of Shahed University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 18 - 65 years old ; DSM-IV criteria for addiction ; healthy condition ; detoxification at least one month before intervention; signed informed consent Exclusion criteria: Addiction to alcohol ; positive history of other psychological disorders ; taking psychiatric drug ; pregnancy and breast feeding ; serious medical disease such as glaucoma ,retention ,epilepsy ,parkinsonism ; allergic reaction to medical herbs ; incidence of side effect
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: Hamilton rating scale for anxiety.;Craving. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: Craving Beliefs Questionnaire.;Quality of life. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: wHO-QOL Brief. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect. Timepoint: 4,8 and12 weeks after starting the medication. Method of measurement: physical examination and checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSayyed Abdalali Moosavyzadeh
Shahed University
Outcome results
None listed